Key facts
- This page summarizes Jian Wang's Form 4 filing for ACM Research, Inc. (ACMR).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Sep 2025, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
On September 18, 2025, the reporting person exercised a previously issued stock option to purchase 30,000 shares of Class A Common Stock of the Issuer.
Footnote F2
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2025.
Footnote F3
The option is fully vested and exercisable.
SEC remarks
Chief Executive Officer and President of ACM Research (Shanghai), Inc., a subsidiary of the Issuer